Oncology Institute (DFPH) Total Current Liabilities (2019 - 2026)

Oncology Institute (DFPH) has reported Total Current Liabilities for 8 consecutive years, with $79.4 million the latest figure, recorded in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $79.4 million, up 33.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $79.4 million (up 33.27% YoY), and the FY2025 annual result was $71.0 million, up 35.9% from the prior year.
• Total Current Liabilities was $79.4 million for Q1 2026 at Oncology Institute, up from $71.0 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $79.4 million in Q1 2026 and troughed at $29.7 million in Q4 2022.
• Average Total Current Liabilities over 5 years is $45.9 million, with a median of $36.1 million recorded in 2022.
• Year-over-year, Total Current Liabilities surged 18271.88% in 2022 and declined 7.26% in 2023.
• Over 5 years, Total Current Liabilities stood at $29.7 million in 2022, then increased by 17.05% to $34.8 million in 2023, then jumped by 50.09% to $52.2 million in 2024, then surged by 35.9% to $71.0 million in 2025, then increased by 11.82% to $79.4 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $79.4 million in Q1 2026, $71.0 million in Q4 2025, and $65.6 million in Q3 2025.